The Effect of Proton Pump Inhibitor and Polaprezinc Combination Therapy for Healing of Endoscopic Submucosal Dissection-induced Ulcer

Exclusion Criteria

• •1. Patients who has taken the medications for ulcer including PPIs, H2 blockers, and mucosal protective agents within 3 months prior to the ESD.
• •2. Patients who has taken steroid or NSAIDswithin 3 months prior to the ESD.
• •3. Patients who has undergone gastrostomy
• •4. Patients with allergy for pantoprazole, polaprezinc, or rebamipide.
• •5. Pregnant or breast feeding.